Citadel Advisors’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Citadel Advisors's PLSE Position: Q3 2026 in Review
Citadel Advisors increased its Pulse Biosciences (PLSE) stake by 137% in Q3 2026, buying an estimated $36.2M and bringing the position to 1,484,416 shares worth $74.1M. The position accounts for 0.01% of the portfolio, ranked #1212.
Citadel Advisors first reported a position in PLSE in Q4 2017 and has held it in 17 quarters since. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Citadel Advisors held 1,484,416 shares of Pulse Biosciences worth $74.1M as of Q3 2026.
- Citadel Advisors bought 857,902 Pulse Biosciences shares in Q3 2026, an estimated $36.2M.
- Pulse Biosciences made up 0.01% of Citadel Advisors's portfolio in Q3 2026, its #1212 holding.
- Citadel Advisors first reported a position in Pulse Biosciences in Q4 2017 and has held it in 17 quarters since.
- 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.